Victory Capital Management Inc Pmv Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$11.4 - $17.18 $13,452 - $20,272	-1,180 Reduced 2.34%	49,330 $587,000
Q1 2022 May 04, 2022	SELL	$14.86 - $23.55 $14.6 Million - $23.1 Million	-981,768 Reduced 95.11%	50,510 $1.05 Million
Q4 2021 Feb 07, 2022	SELL	$19.99 - $30.24 $382,108 - $578,037	-19,115 Reduced 1.82%	1,032,278 $23.8 Million
Q3 2021 Nov 02, 2021	BUY	$26.84 - $36.58 $3.55 Million - $4.83 Million	132,152 Added 14.38%	1,051,393 $31.3 Million
Q2 2021 Aug 03, 2021	BUY	$28.01 - $36.01 $3.37 Million - $4.33 Million	120,240 Added 15.05%	919,241 $31.4 Million
Q1 2021 May 04, 2021	BUY	$30.66 - $49.5 $4.39 Million - $7.09 Million	143,292 Added 21.85%	799,001 $26.3 Million
Q4 2020 Feb 01, 2021	BUY	$31.86 - $61.51 $3.12 Million - $6.02 Million	97,866 Added 17.54%	655,709 $40.3 Million
Q3 2020 Nov 09, 2020	BUY	$35.5 - $38.0 $19.8 Million - $21.2 Million	557,843 New	557,843 $19.8 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.